0 NYSE Companies - September 30, 2024Kartoon Studios’ Largest Revenue Unit, Mainframe Studios, Surges on Strong Business ReboundMainframe currently has multiple series in production for industry giants that include Spin Master, Sony Kids, and Disney Company secures […]Read More
0 NYSE Companies - September 30, 2024Vishay Precision Group Acquires NokraMALVERN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and […]Read More
0 NYSE Companies - September 30, 2024ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep HealthResMed makes it easier for people to manage their sleep health and stay on (continuous positive airway pressure) CPAP treatment by […]Read More
0 NYSE Companies - September 30, 2024AMN Healthcare to Hold Third Quarter 2024 Earnings Conference Call on Thursday, November 7, 2024DALLAS, Sept. 30, 2024 (GLOBE NEWSWIRE) — AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss […]Read More
0 NYSE Companies - September 30, 2024Provident Protection Plus Named a Top Performing Insurance Agency in the U.S. by the Independent Insurance Agents & Brokers of AmericaAUGUSTA, NJ.., Sept. 30, 2024 (GLOBE NEWSWIRE) — Provident Protection Plus, a full-service insurance agency that offers comprehensive insurance programs […]Read More
0 NYSE Companies - September 30, 2024Scorpius Holdings Announces Contract with Premier Clinical-Stage Biotech Company; Opens Door to Future GMP Manufacturing OpportunitiesDURHAM, N.C., Sept. 30, 2024 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc. (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract […]Read More
0 NYSE Companies - September 30, 2024Calidi Biotherapeutics Announces FDA Clearance of the Northwestern University IND Application for CLD-101 Clinical Trial in High-Grade GliomaTrial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade glioma CLD-101 is Calidi’s novel allogeneic […]Read More
0 NYSE Companies - September 30, 2024Annovis Files Three New Patents for Combination Therapies Involving Buntanetap, Trulicity, and ViagraMALVERN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), […]Read More
0 NYSE Companies - September 30, 2024Integer Holdings Corporation to Divest Non-Medical Business for $50 millionPLANO, Texas, Sept. 30, 2024 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and […]Read More
0 NYSE Companies - September 30, 2024AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting– Company is aligned with the FDA on next steps for a 351(k) regulatory pathway to approval for ABP-450 (prabotulinumtoxinA) […]Read More